News
Video
GLP-1 RA antiobesity medications: an introduction
Author(s):
Key Takeaways
- GLP-1 receptor agonists are proving effective in reducing body mass index and enhancing patient health outcomes.
- Patients are increasingly interested in understanding the benefits and mechanisms of these antiobesity medications.
A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.
The new GLP-1 RA antiobesity medications are showing excellent benefits for patient body mass index and health. Patients want to know more. Here’s an introduction with Robert Kushner, MD, has made a career as a researcher and author about overweight, obesity and nutrition. He’s also a doctor who has treated patients for years through Northwestern University’s Feinberg School of Medicine and Northwestern Medicine’s Center for Lifestyle Medicine.
Related Videos
Related Content
